I’m buying a ssDNA library from TriLink and doing SELEX for one target. Assuming I get one specific sequence that will bind with high specificity and affinity. My question is, can I patent that sequence, start conducting a clinical trial and then sell it without permission from TriLink?

Posted on by TriLink BioTech

Dear Alan,

TriLink does not take any claim on an aptamer sequence determined from one of our Nucleic Acid Libraries for Aptamer Selection. Please let us know if you need any additional information.

Best regards,

Joey